Cargando…
Increasing Precision of Clinical Diagnosis of Alzheimer's Disease Using a Combined Algorithm Incorporating Clinical and Novel Biomarker Data
Establishing the in vivo diagnosis of Alzheimer’s disease (AD) or other dementias relies on clinical criteria; however, the accuracy of these criteria can be limited. The diagnostic accuracy is 77% for a clinical diagnosis of AD, even among experts. We performed a review through PubMed of articles r...
Autores principales: | Sabbagh, Marwan N., Lue, Lih-Fen, Fayard, Daniel, Shi, Jiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520815/ https://www.ncbi.nlm.nih.gov/pubmed/28733959 http://dx.doi.org/10.1007/s40120-017-0069-5 |
Ejemplares similares
-
Is There Inflammatory Synergy in Type II Diabetes Mellitus and Alzheimer's Disease?
por: Lue, Lih-Fen, et al.
Publicado: (2012) -
Advance in Plasma AD Core Biomarker Development: Current Findings from Immunomagnetic Reduction-Based SQUID Technology
por: Lue, Lih-Fen, et al.
Publicado: (2019) -
Reduced clinical and postmortem measures of cardiac pathology in subjects with advanced Alzheimer's Disease
por: Beach, Thomas G, et al.
Publicado: (2011) -
Potential Peripheral Biomarkers for the Diagnosis of Alzheimer's Disease
por: Patel, Seema, et al.
Publicado: (2011) -
Amyloid Beta and Tau as Alzheimer’s Disease Blood Biomarkers: Promise From New Technologies
por: Lue, Lih-Fen, et al.
Publicado: (2017)